Board of Directors

Board of Directors

Mark Kroll, PhD – Chairman

Mark is the former Chief Technology Officer of St. Jude Medical, Inc. (NYSE: STJ), and the most prolific inventor of electrical medical devices in the world with more than 260 U.S. Patents. Every Implantable Cardioverter Defibrillator sold has at least one patent attributed to Dr. Kroll. He most recently served as the Senior Vice President and Chief Technology Officer for the Cardiac Rhythm Management division of St. Jude Medical Inc. Prior to that, he served as Vice President of the Tachycardia Business division and in various senior executive roles within St. Jude from 1995 through his retirement in 2005. Previously, he served as Vice President of Research for the Angemed division of Angeion, Inc., where he was instrumental in the development of the technology which led to the first ICD smaller than 90 ml in volume. In addition, he is co-author of the books 'Implantable Cardioverter Defibrillator Therapy' (1996), and "Cardiac Bioelectric Therapy" (in press) among more than 150 other papers, invited presentations, book chapters and abstracts.

Patrick Maguire, MD, PhD

Patrick is a proven leader and a seasoned executive with experience in a variety of senior roles with companies involved in medical devices, pharmaceuticals and biologics. Dr. Maguire has served as the Chief Executive Officer and President of CyberHeart Inc. since 2006. He joined CyberHeart following the acquisition of the oncology assets of Targent Incorporated, where Dr. Maguire served as President, CEO, and Director since 2002. Dr. Maguire oversaw the in-licensing of three compounds and the out-licensing of another, prior to the acquisition of the company. Prior to joining Targent, Dr. Maguire was Vice President of Medical Affairs and Technology Development at VitaGen Incorporated, where he oversaw the preparation of IND's, NDA's, and IDE's and managed VitaGen's clinical trials in acute and chronic liver failure as well as medical and industry collaborations.

James A. Heisch

Jim brings more than 40 years of senior level business experience to NewCardio, including 17 years with Arthur Young & Company where he was an audit partner, and later as the Chief Financial Officer for leading technology companies including Atari, Businessland and Supermac Technology. Additionally, Jim served five years with medical device company Vidamed, Inc., initially as CFO managing all financial and administrative functions in the United States and United Kingdom, and then as President and CEO responsible for worldwide operations. He later joined Worldtalk Corporation as CFO and later was promoted to President, which, under his leadership, was successfully sold to Tumbleweed Communications. Jim served as interim President and CFO of Tumbleweed until June 2001, and continues to sit on Tumbleweed's board of directors and serves as its Audit Committee Chairman. Jim has a bachelor's degree in accounting from San Jose State University and an MBA from the Leavy School of Business at the University of Santa Clara.

Robert N. Blair, M. Inst. P.

Robert was Founder & Prior Chairman, CEO Vivo Medical; Prior President and CEO of Crosspoint Solutions & LSI Logic Europe PLC. CEO of Mobi33, Inc.; 35 years of international medical device & high-tech electronics experience.

Branislav Vajdic, PhD – Co-Founder and Chief Executive Officer

Branislav is a founder of NewCardio and provides the strategic direction for the firm as its CEO. He is a proven creator of new technologies and has commercialized them into industry leading products. A 23 year veteran of Intel where he held various senior management positions including directing the Pentium & Flash memory development teams. He led a small team that designed Intel's first flash memory product and he holds several early Flash memory design patents. Branislav received a Ph.D. in electrical engineering from the University of Minnesota.